Abstract

BackgroundA new technique of oncoplastic breast surgery (OBS) using laparoscopically harvested pedicled omental flap has been developed in the past 10 years. This study aimed to evaluate the feasibility of this technique.MethodsTwenty-five patients underwent OBS using laparoscopically harvested omental flap. Operative time, blood loss, complications, recurrence, and cosmetic outcomes were prospectively analyzed.ResultsBetween June 2010 and March 2014, 25 patients were recruited in our study. The surgery was performed successfully in 24 patients. All these patients recovered uneventfully after the surgery. Mean operative time was 310 min, ranging from 205 to 410 min. Mean blood loss was 70 ml, ranging from 20 to 150 ml. Patients were followed up for 32 months on average, ranging from 6 to 51 months. Four patients complained of mild epigastric discomfort. One patient had local recurrence and distant bone and liver metastasis and died 11 months after the surgery. One patient was diagnosed with metastases in the lung, bone, and liver without local recurrence 2 years after surgery. The cosmetic satisfaction rate was 91.7% and 95.8% by surgeon and patients, respectively.ConclusionOBS with laparoscopically harvested omental flap might be a feasible technique with a good cosmetic outcome.

Highlights

  • A new technique of oncoplastic breast surgery (OBS) using laparoscopically harvested pedicled omental flap has been developed in the past 10 years

  • Breast-conserving surgery (BCS) could provide better esthetic results when compared to mastectomy

  • A nationwide survey in China showed that mastectomy continues to account for 88.8% of surgery for primary breast cancer [3]

Read more

Summary

Introduction

A new technique of oncoplastic breast surgery (OBS) using laparoscopically harvested pedicled omental flap has been developed in the past 10 years. Breast-conserving surgery (BCS) could provide better esthetic results when compared to mastectomy. It has become one of the mainstream surgery for early breast cancer [1,2]. BCS is still not the first option for many patients in China. A nationwide survey in China showed that mastectomy continues to account for 88.8% of surgery for primary breast cancer [3]. A tumor as small as 3 cm may require mastectomy or breast reconstruction. 10% to 30% of patients submitted to BCS may experience breast deformity or defect [4].

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call